Skip to content

Proportion of Hysterectomy After Female Sterilization

A Retrospective Analysis to Describe the Proportion of Hysterectomy After Female Sterilization With Hysteroscopic Device or Tubal Ligation Using Intermountain Healthcare Database in the US

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02532361
Enrollment
10578
Registered
2015-08-25
Start date
2015-08-31
Completion date
2015-12-31
Last updated
2016-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysterectomy

Keywords

Sterilization, Hysteroscopic Device Placement, Tubal Ligation

Brief summary

The objective of this study is to describe the proportion of hysterectomy in patients that had undergone sterilization through hysteroscopic device placement and the patients that had undergone sterilization through tubal ligation.

Interventions

DEVICEHysteroscopic device placement including Essure (ESS305, BAY1454032)

Essure is a permanent, minimally invasive, non-hormonal implantable device used for contraception and Adiana sterilization method is a combination of controlled thermal damage to the lining of the fallopian tube followed by insertion of a non-absorbable biocompatible silicone elastomer matrix within the tubal lumen

Tubal ligation or tubectomy is a surgical procedure for sterilization in which a woman's fallopian tubes are clamped and blocked, or severed and sealed, either method of which prevents eggs from reaching the uterus for implantation

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

* Age: 18 to 49 years at index date * Gender: Female * Diagnosis: Women who underwent hysteroscopic device sterilization procedure * Diagnosis: Women who underwent tubal ligation sterilization procedure (includes laparoscopic tubal ligation), and salpingectomy

Exclusion criteria

* Patients undergoing in-vitro fertilization (IVF) procedures * Embryo transfer, intrauterine * Follicle puncture for oocyte retrieval, any method

Design outcomes

Primary

MeasureTime frameDescription
Percentage of patients having hysterectomy procedure post-sterilization through hysteroscopic device placementRetrospective analysis of 10 year periodThe study will also describe sub-outcomes related to post-sterilization hysterectomy procedure including: i. Average time (in days) from index date (sterilization) to hysterectomy ii. Percentage of patients having hysterectomy (abdominal) iii. Percentage of patients having hysterectomy (vaginal) iv. Percentage of patients having hysterectomy (laproscopically assisted vaginal hysterectomy - LAVH) v. Percentage of patients having hysterectomy (abdominal, vaginal and LAVH)
Percentage of patients having hysterectomy procedure post-sterilization through through tubal ligationRetrospective analysis of 10 year periodThe study will also describe sub-outcomes related to post-sterilization hysterectomy procedure including: i. Average time (in days) from index date (sterilization) to hysterectomy ii. Percentage of patients having hysterectomy (abdominal) iii. Percentage of patients having hysterectomy (vaginal) iv. Percentage of patients having hysterectomy (laproscopically assisted vaginal hysterectomy - LAVH) v. Percentage of patients having hysterectomy (abdominal, vaginal and LAVH)

Other

MeasureTime frameDescription
Percentage of patients having unintended pregnancy post-sterilizationRetrospective analysis of 10 year periodExclusion of any IVF pregnancy, and any pregnancy preceding sterilization
Percentage of patients having unintended ectopic pregnancy post-sterilizationRetrospective analysis of 10 year periodExclusion of any IVF pregnancy, and any pregnancy preceding sterilization
Percentage of patients that have salpingectomy (unilateral, bilateral) subsequent to sterilizationRetrospective analysis of 10 year period
Average time in days from sterilization to salpingectomy and Kaplan-Meier-Estimator curve (number of occurrence over time)Retrospective analysis of 10 year period
Average time in days from sterilization to removal of device inserts other than hysterectomy or salpingectomy and Kaplan-Meier-Estimator curve (number of occurrence over time)Retrospective analysis of 10 year period
Percentage of patients with repeat sterilization surgeryRetrospective analysis of 10 year period
Average time in days from first sterilization to repeat sterilization surgery and Kaplan-Meier-Estimator curve (number of occurrence over time)Retrospective analysis of 10 year period
Percentage of patients who undergo a Modified Hysterosalpingogram (HSG) testRetrospective analysis of 10 year period
Percentage of patients who did not have a Modified HSG and unintentionally got pregnantRetrospective analysis of 10 year period
Percentage of patients having readmission within 30 days of sterilizationRetrospective analysis of 10 year period
Percentage of patients having removal of device inserts other than hysterectomy or salpingectomyRetrospective analysis of 10 year period
Percentage of patients who had Modified HSG and got pregnantRetrospective analysis of 10 year period

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026